A new study conducted by Italian researchers reveals that it is possible to reduce the risk of premature menopause among women who undergo chemotherapy by including a treatment that involves a drug called triptorelin.
The researchers conducted the study on 281 women with breast cancer but had not yet entered menopause.
The women were randomly given either triptorelin or placebo before and during chemotherapy and after one year, the researchers found that over 25 percent of women from placebo group entered menopause due to chemotherapy compared to less than 9 percent of triptorelin group.
The study authors are confident that the new drug could provide more options for breast cancer patients who hope to have children in future.
The results are published in the Journal of the American Medical Association.